C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A01K 67/027 (2006.01) A61K 39/395 (2006.01) A61P 19/10 (2006.01) C07K 14/635 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2628628
Chimeric molecules comprising receptor activator of NF-kB ligand (RANKL) antibodies and parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) peptides are described. Compositions and methods for the treatment of bone diseases are also described.
La présente invention concerne des molécules chimères comprenant un activateur du récepteur d~un anticorps du ligand NF-kB (RANKL) et des peptides de l~hormone parathyroïdienne/de la protéine apparentée à l~hormone parathyroïdienne (PTH/PTHrP). Des compositions et procédés pour le traitement de maladies osseuses sont également décrits.
Boone Thomas Charles
Kostenuik Paul
Shen Wenyan
Amgen Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Rankl antibody-pth/pthrp chimeric molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rankl antibody-pth/pthrp chimeric molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rankl antibody-pth/pthrp chimeric molecules will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1383953